Author

Jan G. M. Klijn

Observed names: J G Klijn, J G M Klijn

Institutions: Erasmus MC, Daniel den Hoed Kliniek

Observed institutions: Mount Sinai Hospital, Erasmus MC, Erasmus MC Cancer Institute, Daniel den Hoed Kliniek

OpenAlex ID: A5113498321

Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer.

1989 · J A Foekens, H Portengen, et al. · PubMed · 217

Bcar1/p130Cas Protein and Primary Breast Cancer: Prognosis and Response to Tamoxifen Treatment

2000 · Silvia van der Flier, Arend Brinkman, et al. · JNCI Journal of the National Cancer Institute · 122

Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer

1989 · John A. Foekens, Henk Portengen, et al. · Cancer · 115

Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy.

2001 · J A Foekens, S Romain, et al. · PubMed · 71

Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer

1999 · J A Foekens, E P Diamandis, et al. · British Journal of Cancer · 56

Receptors for hormones and growth factors and (ONCO)‐gene amplification in human ovarian cancer

1992 · Els M. J. J. Berns, Jan G. M. Klijn, et al. · International Journal of Cancer · 54

Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours

2001 · J H de Witte, J A Foekens, et al. · British Journal of Cancer · 42

Works count: 7

Citation count: 677

H-index: 7

I10-index: 7